Vitamin D status in patients with autoimmune bullous dermatoses: a meta-analysis

References

• Bikle D, Christakos S. New aspects of vitamin D metabolism and action - addressing the skin as source and target. Nat Rev Endocrinol. 2020;16(4):234–252.
   PubMed Web of Science ®Google Scholar
• Gutierrez JA, Parikh N, Branch AD. Classical and emerging roles of vitamin D in hepatitis C virus infection. Semin Liver Dis. 2011;31(4):387–398.
   PubMed Web of Science ®Google Scholar
• Stumpf WE, Sar M, Reid FA, et al. Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science. 1979;206(4423):1188–1190.
   PubMed Web of Science ®Google Scholar
• Carlberg C, Molnar F. Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem. 2012;12(6):528–547.
   PubMed Web of Science ®Google Scholar
• Oda Y, Hu L, Nguyen T, et al. Vitamin D receptor is required for proliferation, migration, and differentiation of epidermal stem cells and progeny during cutaneous wound repair. J Invest Dermatol. 2018;138(11):2423–2431.
   PubMed Web of Science ®Google Scholar
• Oda Y, Hu L, Nguyen T, et al. Combined deletion of the vitamin D receptor and calcium-sensing receptor delays wound re-epithelialization. Endocrinology. 2017;158(6):1929–1938.
   PubMed Web of Science ®Google Scholar
• Hamzaoui K, Ben Dhifallah I, Karray E, et al. Vitamin D modulates peripheral immunity in patients with Behçet's disease. Clin Exp Rheumatol. 2010;28(4 Suppl 60):S50–S7.
   PubMed Web of Science ®Google Scholar
• Maalmi H, Berraïes A, Tangour E, et al. The impact of vitamin D deficiency on immune T cells in asthmatic children: a case-control study. J Asthma Allergy. 2012;5:11–19.
   PubMedGoogle Scholar
• Terrier B, Derian N, Schoindre Y, et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther. 2012;14(5):R221.
   PubMed Web of Science ®Google Scholar
• Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179(3):1634–1647.
   PubMed Web of Science ®Google Scholar
• Islam MA, Khandker SS, Alam SS, et al. Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis. Autoimmun Rev. 2019;18(11):102392.
   PubMed Web of Science ®Google Scholar
• Garcia-Carrasco M, Jimenez-Herrera EA, Galvez-Romero JL, et al. Vitamin D and Sjögren syndrome. Autoimmun Rev. 2017;16(6):587–593.
   PubMed Web of Science ®Google Scholar
• Hiraki LT, Arkema EV, Cui J, et al. Circulating 25-hydroxyvitamin D level and risk of developing rheumatoid arthritis. Rheumatology (Oxford). 2014;53(12):2243–2248.
   PubMed Web of Science ®Google Scholar
• Riancho-Zarrabeitia L, Cuberia M, Munoz P, et al. Vitamin D and antiphospholipid syndrome: A retrospective cohort study and meta-analysis. Semin Arthritis Rheum. 2018;47(6):877–882.
   PubMed Web of Science ®Google Scholar
• An L, Sun MH, Chen F, et al. Vitamin D levels in systemic sclerosis patients: a meta-analysis. Drug Des Devel Ther. 2017;11:3119–3125.
   PubMed Web of Science ®Google Scholar
• Behrens JR, Rasche L, Gieß RM, et al. Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis. Eur J Neurol. 2016;23(1):62–67.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–1012.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
   PubMed Web of Science ®Google Scholar
• Tukaj S, Schmidt E, Recke A, et al. Vitamin D status in patients with bullous pemphigoid. Br J Dermatol. 2013;168(4):873–874.
   PubMed Web of Science ®Google Scholar
• El-Komy MH, Samir N, Shaker OG. Estimation of vitamin D levels in patients with pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2014;28(7):859–863.
   PubMed Web of Science ®Google Scholar
• Joshi N, Minz RW, Anand S, et al. Vitamin D deficiency and lower TGF-β/IL-17 ratio in a North Indian cohort of pemphigus vulgaris. BMC Res Notes. 2014;7:536.
   PubMedGoogle Scholar
• Zarei M, Javanbakht MH, Chams-Davatchi C, et al. Evaluation of vitamin D status in newly diagnosed pemphigus vulgaris patients. Iran J Public Health. 2014;43(11):1544–1549.
   PubMed Web of Science ®Google Scholar
• Marzano AV, Trevisan V, Cairoli E, et al. Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study. Orphanet J Rare Dis. 2015;10(1):8.
   PubMedGoogle Scholar
• Moravvej H, Mozafari N, Younespour S. Serum 25-hydroxy vitamin D level in patients with pemphigus and its association with disease severity. Clin Exp Dermatol. 2016;41(2):142–147.
   PubMed Web of Science ®Google Scholar
• Sarre ME, Annweiler C, Legrand E, et al. Association between bullous pemphigoid and hypovitaminosis D in older inpatients: results from a case-control study. Eur J Intern Med. 2016;31:25–28.
   PubMed Web of Science ®Google Scholar
• Filoni A, Vestita M, Congedo M, et al. Association between psoriasis and vitamin D: Duration of disease correlates with decreased vitamin D serum levels: an observational case-control study. Medicine (Baltimore). 2018;97(25):e11185.
   PubMed Web of Science ®Google Scholar
• Banihashemi M, Nahidi Y, Meibodi NT, et al. Serum vitamin D level in patients with newly diagnosed pemphigus vulgaris. Iranian J Dermatol. 2018;21(4):128–131.
   Google Scholar
• Chang XY, Liu Y, Lai XM. Clinical analysis of serum 25-(OH) vitamin D levels in patients with bullous pemphigoid. Prac Pharm Clin Remedies. 2019;22(12):1262–1265.
   Google Scholar
• Lo Schiavo A, Ruocco E, Brancaccio G, et al. Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies. Clin Dermatol. 2013;31(4):391–399.
   PubMed Web of Science ®Google Scholar
• Akarsu S, Özbağçivan Ö, Dolaş N, et al. Possible triggering factors and comorbidities in newly diagnosed autoimmune bullous diseases. Turk J Med Sci. 2017;47(3):832–840.
   PubMed Web of Science ®Google Scholar
• Reis VM, Toledo RP, Lopez A, et al. UVB-induced acantholysis in endemic Pemphigus foliaceus (Fogo selvagem) and Pemphigus vulgaris. J Am Acad Dermatol. 2000;42(4):571–576.
   PubMed Web of Science ®Google Scholar
• Yamamoto C, Tamai K, Nakano H, et al. Vitamin D3 inhibits expression of pemphigus vulgaris antigen desmoglein 3: Implication of a partial mechanism in the pharmacological effect of vitamin D3 on skin diseases. Mol Med Rep. 2008;1(4):581–583.
   PubMed Web of Science ®Google Scholar
• Yamamoto C, Tamai K, Nakano H, et al. Vitamin D(3) inhibits expression of bullous pemphigoid antigen 1 through post-transcriptional mechanism without new protein synthesis. J Dermatol Sci. 2008;50(2):155–158.
   PubMed Web of Science ®Google Scholar
• Tukaj S, Grüner D, Tukaj C, et al. Calcitriol exerts anti-inflammatory effects in keratinocytes treated with autoantibodies from a patient with bullous pemphigoid. J Eur Acad Dermatol Venereol. 2016;30(2):288–292.
   PubMed Web of Science ®Google Scholar
• Zeeli T, Langberg M, Rotem C, et al. Vitamin D inhibits captopril-induced cell detachment and apoptosis in keratinocytes. Br J Dermatol. 2011;164(1):62–67.
   PubMed Web of Science ®Google Scholar
• Hilger J, Friedel A, Herr R, et al. A systematic review of vitamin D status in populations worldwide. Br J Nutr. 2014;111(1):23–45.
   PubMed Web of Science ®Google Scholar
• Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol. 2014;144(Pt A):138–145.
   PubMed Web of Science ®Google Scholar
• van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab. 2011;25(4):671–680.
   PubMed Web of Science ®Google Scholar
• Ghodsi SZ, Shahram F, Daneshpazhooh M, et al. Osteoporosis in patients with Pemphigus Vulgaris before steroid therapy. Acta Med Iran. 2014;52(12):879–883.
   PubMedGoogle Scholar
• Wohl Y, Dreiher J, Cohen AD. Pemphigus and osteoporosis: a case-control study. Arch Dermatol. 2010;146(10):1126–1131.
   PubMedGoogle Scholar
• Mahdavi K, Amirajam Z, Yazdankhah S, et al. The prevalence and prognostic role of vitamin D deficiency in patients with acute coronary syndrome: a single centre study in South-West of Iran. Heart Lung Circ. 2013;22(5):346–351.
   PubMed Web of Science ®Google Scholar
• Afkhami-Ardekani O, Afkhami-Ardekani A, Namiranian N, et al. Prevalence and predictors of vitamin D insufficiency in adult population of yazd - The sun province in center of Iran. Diabetes Metab Syndr. 2019;13(5):2843–2847.
   PubMed Web of Science ®Google Scholar
• Lagunova Z, Ac P, Lindberg F, et al. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res. 2009;29(9):3713–3720.
   PubMed Web of Science ®Google Scholar